Science of aging

Why do we experience an exponential increase in disease as we age? Are the underlying processes treatable? What are the recent breakthroughs in anti-aging science, and which bottlenecks exist for putting them into practice? The Science of Aging seminar focused on all these questions. Together we discussed the ways in which one can get involved in the field as an entrepreneur or investor.

The seminar on Anti-aging was taught by Martin Borch Jensen, the CSO of Gordian Biotechnology. Prior to founding Gordian, he had an extensive career in academic aging research: after a M.S. in nanotechnology, he received Denmark’s most exclusive doctoral fellowship (EliteForsk) for his Ph.D. in biogerontology at the NIH National Institute on Aging/the University of Copenhagen. He then did postdoctoral research at the Buck Institute for Research on Aging, modifying different aging pathways to extend lifespan in model organisms.

As a postdoc, Martin received the ~$1M NIH Pathway to Independence award to start his own research lab. He returned this award to found Gordian, which is building the first truly scalable therapeutic discovery platform for diseases of aging.

Watch the seminar on our YouTube channel here →